Juan Camilo Santacruz

Juan Camilo Santacruz

Auto-generated profile, based on publicly available information

Juan Camilo Santacruz

J.C. Santacruz Devia, Grupo de Estudio de las eSPondiloArtritis (GESPA)

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JLJohn Londono
John Londono
CPCésar Pacheco-Tena
César Pacheco-Tena
ASAna Maria Santos
Ana Maria Santos
MCMario Humberto Cardiel
Mario Humberto Cardiel
GRGustavo Rodríguez-Salas
Gustavo Rodríguez-Salas
RBRubén Burgos-Vargas
Rubén Burgos-Vargas
To compare the demographic, clinical, and laboratory characteristics, disease onset, and clinical features of radiographic axial Spondyloarthritis (r-axSpA) and non-radiographic axial Spondyloarthritis (nr-axSpA) patients. All patients who attended outpatient spondylarthritis (SpA) clinics at Hospital General de Mexico and the Instituto Nacional de la Nutrición from 1998 to 2005 and met the rheumatologist diagnostic criteria for SpA were selected. Then the SpA patients were classified by European Spondyloarthropathy Study Group criteria (ESSG). We selected SpA patients with axial presentation as axial SpA (axSpA), and they were classified as r-axSpA if they met modified New York (mNY) criteria for sacroiliitis and as nr-axSpA if they did not meet mNY criteria; to compared clinical, demographic, and laboratory test between the subgroups. It included 148 SpA patients; 55 (37.2%) patients had r-axSpA, and 70 (47.3%) had nr-axSpA. The nr-axSpA patients had a lower proportion of males (58.6% vs 78.2%, P < 0.05), lower HLA-B27 frequency (54.3%. vs. 92.7%, P < 0.05), were older at disease onset (21 vs 16 years; P < 0.01) and had a higher frequency of infections at disease onset (9.1% vs 32.9, P < 0.05) than r-axSpA. BASFI (2.9 vs 4.8; P < 0.0001), Dougados functional index (7 vs. 14; P < 0.05), and BASDAI (4.1 vs. 5.2; P < 0.001) were lower in patients with nr-axSpA than r-axSpA, respectively. The factors that most influenced the presentation of r-axSpA were history of uveitis (OR 14, 95% CI 2.3–85), HLA-B27 (OR 7.97, 95% CI, 2.96–122), male sex (OR 6.16, 95% CI, 1.47–25.7), axial enthesopathy count (OR 1.17 95% CI, 1.03–1.33). This study provides insight into the differences between nr-axSpA and r-axSpA in Mexico. Patients with r-axSpA were mainly male, with a younger presentation age, a higher prevalence of HLA-B27, more history of uveitis, fewer episodes of dactylitis, more axial enthesopathy, and higher disease activity than nr-axSpA.

1 January 2023 in Autopsy Case Reports
Verified
Journal Article
Open access
PDF file
MMMarta Juliana Mantilla
Marta Juliana Mantilla
JCJuan Jose Chaves Cabezas
Juan Jose Chaves Cabezas
JSJuan Camilo Santacruz
Juan Camilo Santacruz
GRGustavo Rodríguez-Salas
Gustavo Rodríguez-Salas
IRIgor Rueda
Igor Rueda
JMJulio Cesar Mantilla
Julio Cesar Mantilla
Autops Case Rep, vol.13, e2023430, 2023

20 January 2023 in Revista Colombiana de Reumatología
Verified
Journal Article
Closed access
JSJuan Camilo Santacruz
Juan Camilo Santacruz
MMMarta Juliana Mantilla
Marta Juliana Mantilla
GRGustavo Rodríguez-Salas
Gustavo Rodríguez-Salas
IRIgor Rueda
Igor Rueda
ASAna María Santos
Ana María Santos
JLJohn Londono
John Londono

1 September 2025 in The Journal of Rheumatology
Verified
Journal Article
Open access
PDF file
ICIgor Rueda Cárdenas
Igor Rueda Cárdenas
GRGustavo José Rodriguez
Gustavo José Rodriguez
ASAna María Santos
Ana María Santos
JDJuan Camilo Santacruz Devia
Juan Camilo Santacruz Devia
SASofía Arias-Correal
Sofía Arias-Correal
JLJohn Londono
John Londono
Objective: The Assessment of SpondyloArthritis international Society (ASAS) criteria classify spondyloarthritis (SpA) based on clinical presentation. Although widely applied, the measure’s performance in Colombia’s population remains unclear. This study aimed to characterize a Colombian SpA cohort, identify factors associated with peripheral SpA (pSpA), compare SpA subtypes, assess the performance of ASAS criteria, and compare the ASAS with modified New York (mNY) and European Spondyloarthropathy Study Group (ESSG) criteria. Methods: This cross-sectional study included patients with newly diagnosed SpA by ≥ 1 expert rheumatologist. Participants completed a structured survey, physical examination, imaging, and laboratory tests. Researchers classified patients using ASAS, ESSG, and mNY criteria and compared clinical characteristics across groups. Finally, the performance of the ASAS criteria relative to the rheumatologist’s diagnosis, mNY, and ESSG was analyzed. Results: The study analyzed 461 patients with SpA, of whom 58.1% had pSpA. Patients with axial SpA (axSpA) and pSpA differed significantly in age at onset, initial symptoms, buttock pain, Schober test, sacroiliitis, and HLA alleles. The ASAS criteria demonstrated a sensitivity of 90.8% when compared to rheumatologist diagnosis. Notably, 33.6% and 36.6% of patients classified as having radiographic axSpA (r-axSpA) by mNY or ESSG, respectively, were misclassified as pSpA under ASAS due to unmet entry criteria for axSpA. Conclusion: This large Colombian SpA cohort, predominantly comprising patients with pSpA, revealed distinct clinical and imaging features between axSpA and pSpA. The ASAS criteria showed high sensitivity but failed to classify a subset of patients with radiographic sacroiliitis as having r-axSpA, highlighting limitations in its entry criteria for axSpA.

16 September 2023 in Gaceta Médica de Caracas
Verified
Journal Article
Open access
PDF file
JSJuan Camilo Santacruz
Juan Camilo Santacruz
La artritis psoriásica (APs) es una enfermedad autoinmune sistémica asociada a la psoriasis, conocida ahora dentro de un único espectro llamado enfermedad psoriásica, y otras comorbilidades como lo son enfermedad cardiovascular, síndrome metabólico, inflamación intestinal subclínica, trastornos del estado de ánimo, mayor riesgo de infecciones crónicas y fibromialgia. El compromiso articular en esta enfermedad es de presentación heterogénea, incluyendo tanto las articulaciones periféricas como axiales, acompañadas de otras manifestaciones clínicas como lo son la presencia de entesitis, dactilitis y el compromiso ungueal. Gracias a los avances en el entendimiento de su fisiopatología se ha logrado desarrollar en los últimos años un arsenal terapéutico suficiente para controlar la mayoría de sus dominios clínicos.